Research
| Phil Nadeau Managing Director (646) 562-1336 phil.nadeau@cowen.com Philip Nadeau is a Managing Director and Senior Research Analyst on the biotechnology team at Cowen and Company. He has been at Cowen for ten years, and is responsible for covering 20 large-, mid-, and small- cap biotechnology stocks. He has been recognized in the Wall Street Journals Best on the Street rankings, and his views on biotechnology topics are often quoted by national news services such as Reuters, Bloomberg news, and the Dow Jones Newswires. Prior to joining Cowen, he was a research assistant at Childrens Hospital, Boston. Mr. Nadeau has a Ph.D. in neurobiology from Harvard University and an S.B./M.Eng in electrical engineering and computer science from MIT Health Care- Biotechnology |
